You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ixazomib

Showing 51 - 75 of 142
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma, Lymphoma, Amyloidosis Trial in Worldwide (Ixazomib)

Active, not recruiting
  • Multiple Myeloma
  • +2 more
  • Ixazomib
  • Atlanta, Georgia
  • +23 more
Dec 20, 2021

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial in Boston, Danvers, Newton (Nivolumab, Ixazomib, Dexamethasone)

Active, not recruiting
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Boston, Massachusetts
  • +2 more
May 14, 2021

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial in Canada, United States (Ixazomib, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Ixazomib
  • +3 more
  • Little Rock, Arkansas
  • +23 more
Feb 24, 2022

Refractory Multiple Myeloma Trial in Germany (MLN9708, Pomalidomide 4 MG Oral Capsule, Dexamethasone)

Recruiting
  • Refractory Multiple Myeloma
  • Munich, Bayern, Germany
  • +10 more
Sep 8, 2021

A Study of NINLARO® in Chinese Adults With Multiple Myeloma

Recruiting
  • Multiple Myeloma
  • No intervention
  • Hefei, Anhui, China
  • +11 more
Jun 22, 2022

Newly Diagnosed Multiple Myeloma Trial in West Hollywood (Ixazomib, Lenalidomide)

Recruiting
  • Newly Diagnosed Multiple Myeloma
  • West Hollywood, California
    James R Berenson, MD, Inc.
Oct 23, 2020

AL Amyloidosis Trial in New York (Venetoclax Oral Tablet, 200 mg, FISH assay, Venetoclax Oral Tablet, 400 mg)

Not yet recruiting
  • AL Amyloidosis
  • Venetoclax Oral Tablet, 200 mg
  • +9 more
  • New York, New York
    New York Presbyterian Hospital/Columbia University Irving Medica
Jul 11, 2022

Newly Diagnosed Primary Amyloidosis, Recurrent Primary Amyloidosis, Refractory Primary Amyloidosis Trial in Houston

Recruiting
  • Newly Diagnosed Primary Amyloidosis
  • +2 more
  • Daratumumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 12, 2021

Multiple Myeloma Trial in Toulouse (Ixazomib, Lenalidomide, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Ixazomib
  • +2 more
  • Toulouse, France
    University Hosptial Toulouse
Nov 9, 2020

Lymphoma, T-Cell, Peripheral Trial in United States (Romidepsin, Ixazomib)

Active, not recruiting
  • Lymphoma, T-Cell, Peripheral
  • Chicago, Illinois
  • +6 more
Jan 15, 2021

Relapsed and/or Refractory Multiple Myeloma Trial in Japan (Ixazomib, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Relapsed and/or Refractory Multiple Myeloma
  • Ixazomib
  • +2 more
  • Nagoya, Aichi, Japan
  • +20 more
Dec 18, 2020

Liposarcoma, Malignant Peripheral Nerve Sheath Tumors, Alveolar Soft Part Sarcoma Trial in New York (Selinexor, Ixazomib)

Withdrawn
  • Liposarcoma
  • +4 more
  • New York, New York
    Columbia University Medical Center
Nov 24, 2020

Adult Burkitt Lymphoma, B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between DLBCL and Burkitt Lymphoma, DLBCL

Active, not recruiting
Has Results
  • Adult Burkitt Lymphoma
  • +4 more
  • Chicago, Illinois
  • +4 more
Feb 17, 2022

Multiple Myeloma Trial in Milwaukee (MLN9708, Dexamethasone, Bendamustine (multiple dose levels))

Completed
Has Results
  • Multiple Myeloma
  • Milwaukee, Wisconsin
    Froedtert Hospital and the Medical College of Wisconsin
Sep 30, 2020

Waldenstrom's Macroglobulinemia Trial in Boston (Ixazomib, Dexamethasone, Rituximab)

Completed
Has Results
  • Waldenstrom's Macroglobulinemia
  • Ixazomib
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Aug 20, 2020

Advanced Solid Tumors, Lymphoma Trial in Cleveland (IXAZOMIB)

Completed
Has Results
  • Advanced Solid Tumors
  • Lymphoma
  • IXAZOMIB
  • Cleveland, Ohio
    (unnamed)
Aug 25, 2020

Multiple Myeloma, Relapsed and/or Refractory Multiple Myeloma Trial in United States (Selinexor, Ixazomib, Dexamethasone)

Completed
  • Multiple Myeloma
  • Relapsed and/or Refractory Multiple Myeloma
  • Basking Ridge, New Jersey
  • +6 more
Nov 23, 2020

Multiple Myeloma Trial in United States (Ixazomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Ixazomib
  • +2 more
  • Tucson, Arizona
  • +32 more
Oct 8, 2021

Waldenström Macroglobulinemia Trial in Tianjin (Zanubrutinib,Ixazomib and Dexamethasone)

Recruiting
  • Waldenström Macroglobulinemia
  • Zanubrutinib,Ixazomib and Dexamethasone
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jul 8, 2020

Triple-Negative Breast Cancer Trial in Austria (Ixazomib, Carboplatin)

Terminated
  • Triple-Negative Breast Cancer
  • Wels, Oberösterreich, Austria
  • +11 more
Nov 26, 2020

Precursor Cell Lymphoblastic Leukemia-lymphoma Trial in Spain, United States (Ixazomib)

Withdrawn
  • Precursor Cell Lymphoblastic Leukemia-lymphoma
  • Ixazomib
  • Jackson, Mississippi
  • +6 more
Sep 24, 2020

Multiple Myeloma Trial in United Kingdom (R1: Ixazomib, Lenalidomide, Dexamethasone (IRD) induction therapy - reactive arm, R1:

Recruiting
  • Multiple Myeloma
  • R1: Ixazomib, Lenalidomide, Dexamethasone (IRD) induction therapy - reactive arm
  • +3 more
  • Aberdeen, United Kingdom
  • +109 more
Jun 10, 2021

Multiple Myeloma Trial in New York (ONC201, Ixazomib, Dexamethasone)

Terminated
  • Multiple Myeloma
  • New York, New York
    Icahn School of Medicine at Mount Sinai
May 27, 2020

Multiple Myeloma Trial in France (Ixazomib, Lenalidomide, Dexamethasone)

Recruiting
  • Multiple Myeloma
  • Ixazomib
  • +3 more
  • Bordeaux, France
  • +11 more
Jul 29, 2020

Acute Myeloid Leukemia Trial in Boston (MLN9708, Cytarabine, Daunorubicin)

Recruiting
  • Acute Myeloid Leukemia
  • Boston, Massachusetts
    Massachusetts General Hospital
Jan 18, 2021